These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38686849)

  • 1. A Macrophage Membrane-Functionalized, Reactive Oxygen Species-Activatable Nanoprodrug to Alleviate Inflammation and Improve the Lipid Metabolism for Atherosclerosis Management.
    Qu K; Zhong Y; Zhu L; Mou N; Cao Y; Liu J; Wu S; Yan M; Yan F; Li J; Zhang C; Wu G; Zhang K; Qin X; Wu W
    Adv Healthc Mater; 2024 Oct; 13(26):e2401113. PubMed ID: 38686849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage Membrane Spontaneously Encapsulated Cyclodextrin-Based Nanomedicines for Improving Lipid Metabolism and Inflammation in Atherosclerosis.
    Mou N; Duan X; Qu K; Chen Q; He Z; Cao Y; Zhang K; Qin X; Zhu L; Han Z; Li C; Zhong Y; Wu W
    ACS Appl Mater Interfaces; 2024 Sep; 16(37):49660-49672. PubMed ID: 39240784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of ulcerative colitis
    Sun T; Kwong CHT; Gao C; Wei J; Yue L; Zhang J; Ye RD; Wang R
    Theranostics; 2020; 10(22):10106-10119. PubMed ID: 32929337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines.
    Gao C; Huang Q; Liu C; Kwong CHT; Yue L; Wan JB; Lee SMY; Wang R
    Nat Commun; 2020 May; 11(1):2622. PubMed ID: 32457361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of berberine using bionic nanomaterials for Atherosclerosis therapy.
    Wu H; Zhang L; Dong X; Yang J; Zheng L; Li L; Liu X; Jin M; Zhang P
    Biomed Pharmacother; 2024 Sep; 178():117135. PubMed ID: 39047421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage Membrane-Encapsulated Dopamine-Modified Poly Cyclodextrin Multifunctional Biomimetic Nanoparticles for Atherosclerosis Therapy.
    Zhu L; Zhong Y; Yan M; Ni S; Zhao X; Wu S; Wang G; Zhang K; Chi Q; Qin X; Li C; Huang X; Wu W
    ACS Appl Mater Interfaces; 2024 Jun; 16(25):32027-32044. PubMed ID: 38867426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioengineering CXCR4-overexpressing cell membrane functionalized ROS-responsive nanotherapeutics for targeting cerebral ischemia-reperfusion injury.
    Luo L; Zang G; Liu B; Qin X; Zhang Y; Chen Y; Zhang H; Wu W; Wang G
    Theranostics; 2021; 11(16):8043-8056. PubMed ID: 34335979
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis.
    Dou Y; Chen Y; Zhang X; Xu X; Chen Y; Guo J; Zhang D; Wang R; Li X; Zhang J
    Biomaterials; 2017 Oct; 143():93-108. PubMed ID: 28778000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomimetic-Coated Nanoplatform with Lipid-Specific Imaging and ROS Responsiveness for Atherosclerosis-Targeted Theranostics.
    Ma B; Xu H; Wang Y; Yang L; Zhuang W; Li G; Wang Y
    ACS Appl Mater Interfaces; 2021 Aug; 13(30):35410-35421. PubMed ID: 34286950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity.
    Wang Y; Li L; Zhao W; Dou Y; An H; Tao H; Xu X; Jia Y; Lu S; Zhang J; Hu H
    ACS Nano; 2018 Sep; 12(9):8943-8960. PubMed ID: 30114351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple pathway assessment to predict anti-atherogenic efficacy of drugs targeting macrophages in atherosclerotic plaques.
    Alaarg A; Zheng KH; van der Valk FM; da Silva AE; Versloot M; van Ufford LC; Schulte DM; Storm G; Metselaar JM; Stroes ES; Hamers AA
    Vascul Pharmacol; 2016 Jul; 82():51-9. PubMed ID: 27189780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red Blood Cell Membrane Spontaneously Coated Nanoprodrug Based on Phosphatidylserine for Antiatherosclerosis Applications.
    Cao Y; Han Z; Zhu L; He Z; Mou N; Duan X; Chen Q; Qin X; Zhang K; Qu K; Zhong Y; Wu W
    ACS Appl Mater Interfaces; 2024 Sep; 16(35):46578-46589. PubMed ID: 39172072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications.
    Wang Y; Zhang K; Li T; Maruf A; Qin X; Luo L; Zhong Y; Qiu J; McGinty S; Pontrelli G; Liao X; Wu W; Wang G
    Theranostics; 2021; 11(1):164-180. PubMed ID: 33391468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage membrane-camouflaged biomimetic nanoparticles for rheumatoid arthritis treatment via modulating macrophage polarization.
    Zhou R; Xue S; Cheng Y; Chen Y; Wang Y; Xing J; Liu H; Xu Y; Lin Y; Pei Z; Wei X; Ding J; Li S; Wang K; Yao F; Zhao Y; Ding C; Hu W
    J Nanobiotechnology; 2024 Sep; 22(1):578. PubMed ID: 39300463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis.
    Zhang Y; Yin Y; Zhang W; Li H; Wang T; Yin H; Sun L; Su C; Zhang K; Xu H
    J Nanobiotechnology; 2021 May; 19(1):161. PubMed ID: 34059078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver Fibrosis Amelioration by Macrophage-Biomimetic Polydopamine Nanoparticles via Synergistically Alleviating Inflammation and Scavenging ROS.
    Ma Z; Tian X; Yu S; Shu W; Zhang C; Zhang L; Wang F
    Mol Pharm; 2024 Jun; 21(6):3040-3052. PubMed ID: 38767388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia.
    Liu B; Yan W; Luo L; Wu S; Wang Y; Zhong Y; Tang D; Maruf A; Yan M; Zhang K; Qin X; Qu K; Wu W; Wang G
    J Nanobiotechnology; 2021 Nov; 19(1):374. PubMed ID: 34789284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Athero-inflammatory nanotherapeutics: Ferulic acid-based poly(anhydride-ester) nanoparticles attenuate foam cell formation by regulating macrophage lipogenesis and reactive oxygen species generation.
    Chmielowski RA; Abdelhamid DS; Faig JJ; Petersen LK; Gardner CR; Uhrich KE; Joseph LB; Moghe PV
    Acta Biomater; 2017 Jul; 57():85-94. PubMed ID: 28522412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome-mediated delivery of inflammation-responsive
    Bu T; Li Z; Hou Y; Sun W; Zhang R; Zhao L; Wei M; Yang G; Yuan L
    Theranostics; 2021; 11(20):9988-10000. PubMed ID: 34815799
    [No Abstract]   [Full Text] [Related]  

  • 20. Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment.
    He Z; Chen W; Hu K; Luo Y; Zeng W; He X; Li T; Ouyang J; Li Y; Xie L; Zhang Y; Xu Q; Yang S; Guo M; Zou W; Li Y; Huang L; Chen L; Zhang X; Saiding Q; Wang R; Zhang MR; Kong N; Xie T; Song X; Tao W
    Nat Nanotechnol; 2024 Sep; 19(9):1386-1398. PubMed ID: 38898135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.